ACTV Biotechnology
Provides "accurate and reliable" testing services with its expert staff and state-of-the-art devices.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | €285k | Seed | |
| Total Funding | 000k | ||
Related Content
ACTV Biotechnology, established in Istanbul in 2015, operates as a specialized developer and producer of active ingredients for the cosmetic and pharmaceutical industries. The company's inception followed four years of dedicated research and development that began in 2011. It is managed by CEO Dr. Yakup Bakır and General Manager Dr. Yıldız Bodurlar.
The firm's core business revolves around the production and sale of high-quality active raw materials derived from plants using advanced biotechnological methods. ACTV Biotechnology serves manufacturers of cosmetic and pharmaceutical products by providing them with potent ingredients for applications such as anti-aging, spot removal, and wound healing. In addition to ingredient supply, the company offers testing and analysis services and provides laboratory consumables. Revenue is generated through the sale of these proprietary ingredients, consumables, and service fees from its testing and analysis division.
At the heart of its operations is the patent-pending ProliCell® technology, which utilizes plant stem cells to create its bio-active ingredients. This proprietary process cultivates ingredients from plant cell cultures without soil, significantly reducing water consumption and eliminating dependencies on seasonal or geographical factors. The technology allows for the customization of plant stem cell efficacy through the use of exosomes and small RNAs, enhancing the targeted therapeutic properties of the bio-actives. This method ensures a sustainable and consistent supply of high-quality ingredients, addressing common challenges in traditional plant-based production like content variability and pollution. The company's product portfolio includes a range of cosmetic and pharmaceutical active ingredients marketed under the ProliCell® brand.
Keywords: plant stem cell technology, cosmetic active ingredients, pharmaceutical ingredients, biotechnology, ProliCell, raw material supplier, dermo-cosmetics, sustainable ingredients, cell culture, bio-actives, anti-aging compounds, wound healing agents, skin care ingredients, plant-derived exosomes, small RNAs, biotechnological production, cosmetic testing, lab consumables, ingredient development, natural actives